bitcoins business Top Knowledge

Zou Yingguang, General Manager of CITIC Securities: It is expected that the demand for cross-border investment and financing at home and abroad will be further released. At the investor open day of CITIC Securities in 2024, Zou Yingguang, General Manager of CITIC Securities, said that the demand for two-way cross-border investment and financing is very strong, whether it is a China enterprise "going abroad" or an overseas investor "coming to China". Among them, with the rapid evolution of China's new open economic system, cross-border finance will usher in greater development space, and securities companies will be in cross-border finance. In the medium and long term, China's macro securitization rate is still accelerating, the internationalization of Chinese-funded enterprises will continue to increase, and the opening up of China's capital market will continue to increase. It is expected that the demand for cross-border investment and financing from domestic and foreign customers will be further released.Binhua Co., Ltd. set up a new equipment technology company in Shandong. According to the enterprise search APP, Shandong Hualu Dingcheng Equipment Technology Co., Ltd. was established recently. The legal representative is Dong Hongbo, with a registered capital of 10 million yuan. Its business scope includes: cloud computing equipment technical services; Intelligent basic manufacturing equipment manufacturing; Intelligent basic manufacturing equipment sales. Enterprise equity penetration shows that the company is wholly owned by Binhua shares.Zhaoyi Innovation established a management consulting company in Zhuhai. According to the enterprise search APP, Zhuhai Lingchuang Management Consulting Co., Ltd. was recently established with a registered capital of 5 million yuan, and its business scope includes: enterprise management consulting. Enterprise survey shows that the company is wholly owned by Zhaoyi Innovation.

The turnover of Shanghai, Shenzhen and Beijing exceeded 1 trillion yuan, 15.6 billion yuan more than the previous day. Up to now, the turnover of Shanghai, Shenzhen and Beijing exceeded 1 trillion yuan, 15.6 billion yuan more than the previous day. Among them, the turnover of Shanghai Stock Exchange was 378.3 billion yuan, that of Shenzhen Stock Exchange was 611.9 billion yuan, and that of Beizheng 50 was 10.5 billion yuan.The Chinese medicine sector collectively pulled up Panlong Pharmaceutical's linear daily limit, Panlong Pharmaceutical's linear daily limit, Xiangxue Pharmaceutical, Kunyao Group, Huasen Pharmaceutical, Jingxin Pharmaceutical, Xinguang Pharmaceutical and Changyao Holdings followed suit.At the close of early trading, the main contracts of domestic futures rose more and fell less. Fuel oil rose by nearly 4%, coke, Shanghai nickel, low sulfur fuel oil (LU), SC crude oil and coking coal rose by over 2%, and glass, sugar, liquefied petroleum gas (LPG) and alumina rose by over 1%. In terms of decline, the European line of container transportation fell by more than 2%, and pigs fell by more than 1%.

The personal pension system has been extended to the whole country. On December 12th, the Ministry of Human Resources and Social Security and other five departments issued the Notice on the Full Implementation of the Personal Pension System. Since December 15th, the personal pension system has been extended to the whole country from 36 pilot cities (regions). (Xinhua News Agency)The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.Afternoon comment: the index opened lower and went higher, and the index rose more than 1% in half a day. The concept of ice and snow industry rose in early trading, and the three major indexes opened lower and went higher in early trading, and the index rose more than 1% in half a day. In terms of sectors, the concept of ice and snow industry rose in early trading, with Jingxue saving energy by 20cm, and Rhine Sports, Snowman and Dalian Shengya trading daily. The retail sector has experienced a daily limit, and Zhongbai Group, Youa Shares, Friendship Group and other collective daily limit; Chinese medicine stocks fluctuated strongly, and Panlong Pharmaceutical had a daily limit; The concept of humanoid robot continued to pull back, and Fenda Technology led the decline; Sora concept stocks bottomed out in early trading, and Fushi Holdings was among the top losers; The concept of machine vision was weakly adjusted, and Taier shares fell by a word. Overall, stocks rose more and fell less, with more than 2,900 stocks rising. On the disk, the ice and snow industry, duty-free shops and retail sectors were among the top gainers, while PEEK materials, automation equipment and science and technology innovation new shares were among the top losers.